SCHEMBL23665186

SCHEMBL23665186

CCCOc1ccc(C(F)(F)F)cc1C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 2/20 0.43
ATM Q13315 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
PPARG P37231 3/20 0.39
PPARD Q03181 3/20 0.39
PPARA Q07869 3/20 0.39
HTT P42858 3/20 0.39
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 2/20 0.39
SCN8A Q9UQD0 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
PDE2A O00408 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12668253 0.89 CYP1A2 (0.52) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL16951779 0.88 L3MBTL1 (0.42) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL13130473 0.84 KDM4E (0.51) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL14471138 0.80 PPARG (0.51) L3MBTL1ALDH1A1HSD17B10PTGDR2PPARG
SCHEMBL9945953 0.79 HTR2A (0.46) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL10104549 0.78 L3MBTL1 (0.45) L3MBTL1MAPTATMLMNAALDH1A1
SCHEMBL24781012 0.78 HTR2C (0.53) SLC6A4
SCHEMBL10352193 0.78 L3MBTL1 (0.60) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL12889916 0.77 ALDH1A1 (0.42) L3MBTL1MAPTATMLMNACYP1A2
SCHEMBL9945954 0.77 ALDH1A1 (0.48) L3MBTL1MAPTATMLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210221784-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PAIN UNIVERSITÉ DE STRASBOURG (FR) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221784-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PAIN ACHE, TRPV1, OPRL1 L3MBTL1 4614/4885MAPT 572/4885ATM 3074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.